A retrospective study of the efficacy and tolerability of Levetiracetam (Keppra) as a first line monotherapy in childhood epilepsy

Ann Connolly

Tallaght Hospital

Ann is qualified in the disciplines of intellectual disability nursing and children’s nursing. She took up a role as a clinical nurse specialist for neurology in 2006 in the national children’s hospital. She qualified as the first Advanced Nurse Practitioner for children’s epilepsy in Ireland in 2012. She has held the post of chair of the Irish Epilepsy Nurses group from 2013- 2015.

Abstract

Background Levetiracetam is an anticonvulsant licensed as monotherapy in those over 16 years and as add-on therapy in childhood epilepsy since 2005. Off-label use of Levetiracetam has increased considerably over the last... [ view full abstract ]

Authors

  1. Ann Connolly (Tallaght Hospital)
  2. Mary Quirke (TCPHI, Trinity College Dublin)
  3. suzanne crowley (Children’s University Hospital, Temple St)
  4. Grainne Griffin (Our Lady's Children's Hospital, Crumlin)
  5. Eadaoin Hayes (Cork University Hospital)
  6. Maria Keegan (Our Lady's Children's Hospital, Crumlin)
  7. David Webb (Tallaght Hospital/Our Lady's Children's Hospital, Crumlin)

Topic Area

Topics: Children's Healthcare

Session

CH2 » Children's Healthcare 2 (15:00 - Wednesday, 9th November, Seminar Room 0.30)

Presentation Files

The presenter has not uploaded any presentation files.